Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Hikma Pharmaceuticals Llc, explained in plain language.
This study allows a small group of patients with acute myeloid leukemia (AML) to continue receiving a generic oral version of the drug azacitidine after they finished a previous trial. The main goal is to monitor the safety and side effects of the drug when taken for a longer per…
Phase: NA • Sponsor: Hikma Pharmaceuticals LLC • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC